ArticleCardiovascular diabetology2020

Preventing major adverse cardiovascular events by SGLT-2 inhibition in patients with type 2 diabetes: the role of kidney.

Dario Giugliano et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.